Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group Study

Direct acting antivirals (DAA) have recently been developed to treat patients with hepatitis C virus (HCV) infection, and interferon-free DAA treatment has improved the cure rate of patients. However, the occurrence rate of hepatocellular carcinoma (HCC) following HCV eradication remains unknown. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tani, Joji, Morishita, Asahiro, Sakamoto, Teppei, Takuma, Kei, Nakahara, Mai, Fujita, Koji, Oura, Kyoko, Tadokoro, Tomoko, Mimura, Shima, Nomura, Takako, Yoneyama, Hirohito, Kobara, Hideki, Himoto, Takashi, Tsutsui, Akemi, Senoh, Tomonori, Nagano, Takuya, Ogawa, Chikara, Moriya, Akio, Deguchi, Akihiro, Takaguchi, Kouichi, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038998/
https://www.ncbi.nlm.nih.gov/pubmed/32194718
http://dx.doi.org/10.3892/ol.2020.11341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038998/
https://www.ncbi.nlm.nih.gov/pubmed/32194718
http://dx.doi.org/10.3892/ol.2020.11341

Ejemplares similares